Loading organizations...
Bright Biotech is a contract manufacturing and development organization based in Manchester, England, that utilizes tobacco plant chloroplasts as bioreactors to produce recombinant proteins. The company specializes in manufacturing specific growth factors for cell culture and regenerative medicine, serving diverse commercial markets that include cultivated meat, human nutrition, animal nutrition, personal care, agriculture, and therapeutics. Operating as a business-to-business supplier within the broader biotechnology sector, the firm provides scalable protein production solutions designed for both specialized research and development and large-scale industrial applications. To support its operational scaling efforts and technological initiatives, the enterprise has raised a total of $3.33 million in funding to date, which includes a $3.2 million oversubscribed seed round secured in 2023. Bright Biotech was established in 2019 by co-founders Anil Day, Farid Khan, Mohammad El Hajj, Rania Deranieh, and Tariq Ali.
Bright Biotech has raised $3.2M across 1 funding round.
Bright Biotech has raised $3.2M in total across 1 funding round.
Bright Biotech has raised $3.2M across 1 funding round. Most recently, it raised $3.2M Seed in November 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 22, 2022 | $3.2M Seed | FoodLabs | BIG Idea Ventures, CPT Capital, HackCapital | Announced |
Bright Biotech has raised $3.2M in total across 1 funding round.
Bright Biotech's investors include FoodLabs, Big Idea Ventures, CPT Capital, HackCapital.
